VOYA Investment Management
CRSP icon

VOYA Investment Management’s CRISPR Therapeutics CRSP Stock Holding History

VOYA Investment Management’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13M Buy
23,717
+202
+0.9% +$10.7K ﹤0.01% 1418
2025
Q4 		$1.23M Sell
23,515
-5,296
-18% -$317K ﹤0.01% 1410
2025
Q3 		$1.87M Sell
28,811
-7,540
-21% -$433K ﹤0.01% 1264
2025
Q2 		$1.77M Buy
36,351
+22,481
+162% +$870K ﹤0.01% 1353
2025
Q1 		$472K Buy
13,870
+5,210
+60% +$221K ﹤0.01% 1895
2024
Q4 		$341K Hold
8,660
– – ﹤0.01% 2132
2024
Q3 		$407K Sell
8,660
-7,795
-47% -$396K ﹤0.01% 2114
2024
Q2 		$889K Sell
16,455
-9,891
-38% -$572K ﹤0.01% 1676
2024
Q1 		$1.8M Hold
26,346
– – ﹤0.01% 1383
2023
Q4 		$1.65M Buy
26,346
+6,151
+30% +$340K ﹤0.01% 1453
2023
Q3 		$917K Buy
20,195
+7,936
+65% +$410K ﹤0.01% 1680
2023
Q2 		$688K Sell
12,259
-225
-2% -$12.8K ﹤0.01% 1895
2023
Q1 		$565K Sell
12,484
-9,645
-44% -$468K ﹤0.01% 1982
2022
Q4 		$900K Sell
22,129
-55
-0.2% -$2.92K ﹤0.01% 1693
2022
Q3 		$1.45M Buy
+22,184
New +$1.61M ﹤0.01% 1458
2020
Q1 		– Sell
-3,793
Closed -$231K – 2638
2019
Q4 		$231K Buy
+3,793
New +$207K ﹤0.01% 2308

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VOYA Investment Management's CRSP Position: Q1 2026 in Review

VOYA Investment Management increased its CRISPR Therapeutics (CRSP) stake by 0.86% in Q1 2026, buying an estimated $10.7K and bringing the position to 23,717 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1418.

VOYA Investment Management first reported a position in CRSP in Q4 2019 and has held it in 16 quarters since. The position peaked at $1.87M in Q3 2025. 488 funds tracked by Wall St. Rank hold CRSP as of Q1 2026.

  • VOYA Investment Management held 23,717 shares of CRISPR Therapeutics worth $1.13M as of Q1 2026.
  • VOYA Investment Management bought 202 CRISPR Therapeutics shares in Q1 2026, an estimated $10.7K.
  • CRISPR Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1418 holding.
  • VOYA Investment Management first reported a position in CRISPR Therapeutics in Q4 2019 and has held it in 16 quarters since.
  • VOYA Investment Management's CRISPR Therapeutics position peaked at $1.87M in Q3 2025.
  • 488 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.